NCT05980481 2025-09-29
A Study of RC48-ADC Combination Therapies as First-line Treatment in Advanced Metastatic Gastric Cancer
RemeGen Co., Ltd.
Phase 2/3 Active not recruiting
RemeGen Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital
Sun Yat-sen University